Science and Technology

Messenger RNA platforms have moved far beyond their early identity as vaccine technologies. Their expansion into oncology, rare diseases, cardiovascular medicine, and beyond reflects a convergence of scientific validation, manufacturing advantages, regulatory learning, and unmet clinical need. The same properties that enabled rapid pandemic response are now being leveraged to reshape how medicines are designed and delivered.From Proof of Concept to Broad Clinical ConfidenceThe worldwide rollout of mRNA vaccines offered extensive real-world confirmation that synthetic mRNA can be effective, scalable, and generally well tolerated, with hundreds of millions of administered doses showing that short-lived protein production can trigger strong immune…

Electrolyzers use electricity to separate water into hydrogen and oxygen, and their overall economics shape whether clean hydrogen can rival fossil-based options in sectors such as industry, transportation, and energy storage. In the past, limited efficiency and high upfront costs restricted widespread use. Over the last decade, materials science has driven major advances, transforming catalysts, membranes, electrodes, and structural elements. These innovations have steadily reduced system costs per kilowatt while boosting efficiency and operational lifespan.Key factors shaping the overall cost of electrolyzersThe cost of an electrolyzer is not driven by any single component, so progress emerges from a range of…

Neural Processing Units, commonly referred to as NPUs, are purpose-built processors engineered to boost artificial intelligence and machine learning tasks. While CPUs manage broad, general operations and GPUs deliver exceptional parallel graphics and computation, NPUs concentrate on matrix calculations, inference processes, and highly efficient on-device training. In addition to NPUs, the wider family of AI chips encompasses dedicated accelerators embedded within system-on-a-chip architectures or supplied as standalone components for PCs and servers.Over the past five years, AI workloads have shifted from cloud-centric processing toward on-device intelligence. This shift is driven by latency requirements, privacy concerns, and the need for energy…

Synthetic biology first gained prominence through its impact on pharmaceuticals, where engineered microbes produce insulin, vaccines, and complex biologic drugs. Over the past decade, the same core capabilities—precise genetic design, scalable fermentation, and data-driven optimization—have matured and become cost-effective enough to address challenges far beyond medicine. As a result, synthetic biology is now expanding rapidly into materials science, targeting sectors such as textiles, construction, packaging, and electronics.This expansion is driven by a convergence of technological readiness, market demand for sustainability, and limitations of traditional material manufacturing.Technologies Driving the Widespread GrowthMultiple technological breakthroughs have increasingly reduced the obstacles to using synthetic…

Artificial intelligence is rapidly moving from experimental deployments to mission-critical systems across regulated industries such as finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals. As AI increasingly influences decisions with legal, ethical, and societal impact, governance is no longer optional. It is becoming a foundational requirement driven by regulation, risk management, and public accountability.The Expanding Role of AI in High-Stakes EnvironmentsRegulated industries adopt AI to improve efficiency, accuracy, and scalability. Examples include credit scoring models in banking, diagnostic algorithms in healthcare, fraud detection in insurance, algorithmic trading in capital markets, and predictive maintenance in utilities. These systems often operate at scale…

Artificial intelligence is swiftly shifting from small-scale trials to essential, high-stakes applications within regulated fields like finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals, and as AI increasingly shapes decisions carrying legal, ethical, and social consequences, oversight has ceased to be optional and is instead evolving into a fundamental obligation driven by regulatory pressure, risk mitigation, and public responsibility.The Growing Influence of AI Across Critical Operational SettingsRegulated industries are increasingly leveraging AI to boost efficiency, enhance precision, and expand operational capacity; for instance, banks rely on credit assessment models, healthcare uses diagnostic algorithms, insurance firms deploy fraud‑detection systems, capital markets employ…

Personalized medicine aims to tailor prevention, diagnosis, and treatment to the unique biological, environmental, and lifestyle characteristics of each patient. Over the past decade, this approach has moved from concept to practice, reshaping how therapies are developed and how clinical trials are designed. Advances in genomics, data science, and digital health are accelerating this transformation, while regulatory agencies and healthcare systems adapt to support more precise and patient-centered research models.Genomics and Multi-Omics at the Heart of AdvancementThe sharp decline in genome sequencing costs and the rise of multi-omics technologies have fundamentally altered personalized medicine.Genomics: Whole-genome and exome sequencing make it…